BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 7542672)

  • 1. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring.
    Shah M; Foreman DM; Ferguson MW
    J Cell Sci; 1995 Mar; 108 ( Pt 3)():985-1002. PubMed ID: 7542672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralising antibody to TGF-beta 1,2 reduces cutaneous scarring in adult rodents.
    Shah M; Foreman DM; Ferguson MW
    J Cell Sci; 1994 May; 107 ( Pt 5)():1137-57. PubMed ID: 7929624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of scarring in adult wounds by neutralising antibody to transforming growth factor beta.
    Shah M; Foreman DM; Ferguson MW
    Lancet; 1992 Jan; 339(8787):213-4. PubMed ID: 1346175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An activin receptor-like kinase 5 inhibitor reduces collagen deposition in a rat dermal incision wound healing model.
    Bian F; Render J; Ren XD; Chio C; Chan K; Boys M; Lala DS; Pocalyko D
    Plast Reconstr Surg; 2011 Nov; 128(5):451e-459e. PubMed ID: 22030504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibiting scar formation in rat cutaneous wounds by blocking TGF-beta signaling].
    Liu W; Chua CH; Wu XL; Wang DR; Yin DM; Cui L; Cao YL; Longaker MT
    Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(1):31-6. PubMed ID: 12757642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of elevated plasma transforming growth factor-beta1 levels in wound healing.
    Shah M; Revis D; Herrick S; Baillie R; Thorgeirson S; Ferguson M; Roberts A
    Am J Pathol; 1999 Apr; 154(4):1115-24. PubMed ID: 10233850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of suramin on healing adult rodent dermal wounds.
    Chamberlain J; Shah M; Ferguson MW
    J Anat; 1995 Feb; 186 ( Pt 1)(Pt 1):87-96. PubMed ID: 7649820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor beta s and wound healing.
    O'Kane S; Ferguson MW
    Int J Biochem Cell Biol; 1997 Jan; 29(1):63-78. PubMed ID: 9076942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mathematical model for collagen fibre formation during foetal and adult dermal wound healing.
    Dale PD; Sherratt JA; Maini PK
    Proc Biol Sci; 1996 May; 263(1370):653-60. PubMed ID: 8677263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor beta 3 (TGF beta 3) accelerates wound healing without alteration of scar prominence. Histologic and competitive reverse-transcription-polymerase chain reaction studies.
    Wu L; Siddiqui A; Morris DE; Cox DA; Roth SI; Mustoe TA
    Arch Surg; 1997 Jul; 132(7):753-60. PubMed ID: 9230861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the fetal fibroblast and transforming growth factor-beta in a model of human fetal wound repair.
    Lin RY; Adzick NS
    Semin Pediatr Surg; 1996 Aug; 5(3):165-74. PubMed ID: 8858763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-beta: a fibrotic factor in wound scarring and a potential target for anti-scarring gene therapy.
    Liu W; Wang DR; Cao YL
    Curr Gene Ther; 2004 Mar; 4(1):123-36. PubMed ID: 15032619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta stimulates wound healing and modulates extracellular matrix gene expression in pig skin: incisional wound model.
    Quaglino D; Nanney LB; Ditesheim JA; Davidson JM
    J Invest Dermatol; 1991 Jul; 97(1):34-42. PubMed ID: 2056191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody to transforming growth factor beta reduces collagen production in injured peripheral nerve.
    Nath RK; Kwon B; Mackinnon SE; Jensen JN; Reznik S; Boutros S
    Plast Reconstr Surg; 1998 Sep; 102(4):1100-6; discussion 1107-8. PubMed ID: 9734429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta1, -beta2, and -beta3 in vivo: effects on normal and mitomycin C-modulated conjunctival scarring.
    Cordeiro MF; Reichel MB; Gay JA; D'Esposita F; Alexander RA; Khaw PT
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):1975-82. PubMed ID: 10440251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermal transforming growth factor-beta responsiveness mediates wound contraction and epithelial closure.
    Martinez-Ferrer M; Afshar-Sherif AR; Uwamariya C; de Crombrugghe B; Davidson JM; Bhowmick NA
    Am J Pathol; 2010 Jan; 176(1):98-107. PubMed ID: 19959810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of topical transforming growth factor-beta2 and anti-transforming growth factor-beta2,3 on scarring in pigs.
    Brahmatewari J; Serafini A; Serralta V; Mertz PM; Eaglstein WH
    J Cutan Med Surg; 2000 Jul; 4(3):126-31. PubMed ID: 11003716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-beta 3 decreases type I collagen and scarring after labioplasty.
    Hosokawa R; Nonaka K; Morifuji M; Shum L; Ohishi M
    J Dent Res; 2003 Jul; 82(7):558-64. PubMed ID: 12821719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic TGF-beta antagonist accelerates wound healing and reduces scarring.
    Huang JS; Wang YH; Ling TY; Chuang SS; Johnson FE; Huang SS
    FASEB J; 2002 Aug; 16(10):1269-70. PubMed ID: 12153996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of glial scarring in the injured rat brain by a recombinant human monoclonal antibody to transforming growth factor-beta2.
    Logan A; Green J; Hunter A; Jackson R; Berry M
    Eur J Neurosci; 1999 Jul; 11(7):2367-74. PubMed ID: 10383626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.